Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Glucagon Receptor Signaling and Lipid Metabolism

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Propagation of Spermatogonial Stem Cell-Like Cells From Infant Boys

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Development and Feasibility of a Regulated, Supramaximal High-Intensity Training Program Adapted for Older Individuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Muscle Activation During ACL Injury Risk Movements in Young Female Athletes: A Narrative Review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Investigating Intestinal Glucagon after Roux-en-Y Gastric Bypass Surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Glucagon is secreted from the pancreatic alpha cells upon hypoglycemia and stimulates hepatic glucose production. Type 2 diabetes is associated with dysregulated glucagon secretion, and increased glucagon concentrations contribute to the diabetic hyperglycemia. Antagonists of the glucagon receptor have been considered as glucose-lowering therapy in type 2 diabetes patients, but their clinical applicability has been questioned because of reports of therapy-induced increments in liver fat content and increased plasma concentrations of low-density lipoprotein. Conversely, in animal models, increased glucagon receptor signaling has been linked to improved lipid metabolism. Glucagon acts primarily on the liver and by regulating hepatic lipid metabolism glucagon may reduce hepatic lipid accumulation and decrease hepatic lipid secretion. Regarding whole-body lipid metabolism, it is controversial to what extent glucagon influences lipolysis in adipose tissue, particularly in humans. Glucagon receptor agonists combined with glucagon-like peptide 1 receptor agonists (dual agonists) improve dyslipidemia and reduce hepatic steatosis. Collectively, emerging data support an essential role of glucagon for lipid metabolism.

OriginalsprogEngelsk
Artikelnummer413
TidsskriftFrontiers in physiology
Vol/bind10
Udgave nummerAPR
Sider (fra-til)1-11
Antal sider11
ISSN1664-042X
DOI
StatusUdgivet - apr. 2019

ID: 57549192